Protagonist Therapeutics, Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protagonist Therapeutics, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Protagonist Therapeutics, Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $10.3M, a 403% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $10.3M +$8.22M +403% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $387K -$2.17M -84.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $954K -$2.11M -68.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $1.5M -$2.05M -57.6% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.04M -$1.99M -49.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.56M -$1.93M -43% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.06M -$1.88M -38% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $3.55M -$1.82M -33.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.02M -$326K -7.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.49M -$168K -3.61% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4.94M -$14K -0.28% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $5.37M +$136K +2.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $4.35M -$1.16M -21.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $4.65M -$1.13M -19.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $4.95M -$1.09M -18.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $5.24M -$1.06M -16.8% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $5.51M -$1.03M -15.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $5.78M -$999K -14.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $6.04M -$1.46M -19.4% Dec 31, 2019 10-K 2021-03-10
Q3 2019 $6.3M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $6.54M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $6.78M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $7.5M Jan 1, 2019 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.